| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14aced038f8399de27ad3c4f67f8eedc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a66a0324cf4b3ea6cbfbf10326be4414
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eadd341e48d82ad37423d3b0cb28146a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff96005af8c6d84f6e55a41ead1b7353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_280cb91e9608ce6f8775a42ba8e6ddf6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 |
| filingDate |
2011-04-04^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-09-04^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dac9e820ab7ed9ff610082b119712181
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cea049a539bb112233e56e5c68b1dbf2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fa21dcfbdad8f7ef5669d6b61b0db3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a144affd63aea622bc3573f7ebd0e046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac9ae7548315bf6a8fd25baa0b9d2954 |
| publicationDate |
2012-09-04^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8258315-B2 |
| titleOfInvention |
Process for forming amorphous atorvastatin |
| abstract |
A process for forming amorphous atorvastatin comprising the steps of dissolving atorvastatin in a non-hydroxylic solvent and removing the solvent by freeze-drying, as well as processes of dissolving atorvastatin in a hydroxylic solvent with a solubilizing agent or an alkalizing agent or an antioxidant and removing the solvent by freeze-drying to afford amorphous atorvastatin. |
| priorityDate |
2004-10-28^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |